Continuous glucose monitoring in 2013

Diabetes Technology and Therapeutics

Volumn 16, Issue , 2014, Pages S11-S16

  Battelino, Tadej ^a   Bode, Bruce W ^b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^b ATLANTA DIABETES ASSOCIATES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

AGED; BLOOD GLUCOSE MONITORING; BODY POSITION; CHILD; COGNITION; CONTINUOUS GLUCOSE MONITORING; ENDOTHELIAL DYSFUNCTION; GERIATRIC PATIENT; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEIVER OPERATING CHARACTERISTIC; SLEEP;

EID: 84907831499     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.1502     Document Type: Note

References (20)

1. Weinzimer SA. Continuous glucose monitoring in young children: Satisfaction without success? Diabetes Technol Ther 2012;14:753-55.
2. Heinemann L, Franc S, Phillip M, Battelino T, Ampudia-Blasco FJ, Bolinder J, Diem P, Pickup J, Hans Devries J. Reimbursement for continuous glucose monitoring: A European view. J Diabetes Sci Technol 2012;6:1498-502.
3. Brancato D, Saura G, Fleres M, Ferrara L, Scorsone A, Aiello V, Noto AD, Spano L, Provenzano V. Prognostic accuracy of continuous glucose monitoring in the prediction of diabetes mellitus in children with incidental hyperglycemia: Receiver operating characteristic analysis. Diabetes Technol Ther 2013;15:580-85.
4. Mensh BD, Wisniewski NA, Neil BM, Burnett DR. Susceptibility of interstitial continuous glucose monitor performance to sleeping position. J Diabetes Sci Technol 2013;7:863-70.
5. Battelino T, Conget I, Olsen B, Schütz-Fuhrmann I, Hommel E, Hoogma R, Schierloh U, Sulli N, Bolinder J; SWITCH Study Group. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: A randomised controlled trial. Diabetologia 2012;55:3155-62.
6. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: Evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care 2010;33:17-22.
7. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011;34:795-800.
8. Fonda SJ, Salkind SJ, Walker MS, Chellappa M, Ehrhardt N, Vigersky RA. Heterogeneity of responses to real-time continuous glucose monitoring (RT-CGM) in patients with type 2 diabetes and its implications for application. Diabetes Care 2013;36:786-92.
9. Fang FS, Li ZB, Li CL, Tian H, Li J, Cheng XL. Influence of glycemic variability on the HbA1c level in elderly male patients with type 2 diabetes. Intern Med 2012;51:3109-13.
10. Pearce KL, Noakes M, Wilson C, Clifton PM. Continuous glucose monitoring and cognitive performance in type 2 diabetes. Diabetes Technol Ther 2012;14:1126-33.
11. Rizzo MR, Marfella R, Barbieri M, Boccardi V, Vestini F, Lettieri B, Canonico S, Paolisso G. Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care 2010;33:2169-74.
12. Torimoto K, Okada Y, Mori H, Tanaka Y. Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol 2013;12:1.
13. Buscemi S, Re A, Batsis JA, Arnone M, Mattina A, Cerasola G, Verga S. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in type 2 diabetes. Diabet Med 2010;27:872-78.
14. Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW, Kaufman FR; ASPIRE In-Home Study Group. Threshold-based insulinpump interruption for reduction of hypoglycemia. N Engl J Med 2013;369:224-32.
15. Nimri R, Muller I, Atlas E, Miller S, Kordonouri O, Bratina N, Tsioli C, Stefanija MA, Danne T, Battelino T, Phillip M. Night glucose control with MD-Logic artificial pancreas in home setting: A single blind, randomized crossover trialinterim analysis. Pediatr Diabetes 2013; Aug. 15. [Epub ahead of print]; DOI: 10.1111/pedi.12071.
16. Khalil AB, Beshyah SA, Abu Awad SM, Benbarka MM, Haddad M, Al-Hassan D, Kahwatih M, Nagelkerke N. Ramadan fasting in diabetes patients on insulin pump therapy augmented by continuous glucose monitoring: An observational real-life study. Diabetes Technol Ther 2012;14:813-18.
17. O'Neal DN, Adhya S, Jenkins A, Ward G, Welsh JB, Voskanyan G. Feasibility of adjacent insulin infusion and continuous glucose monitoring via the Medtronic Combo-Set. J Diabetes Sci Technol 2013;7:381-88.
18. Kaiserman K, Buckingham BA, Prakasam G, Gunville F, Slover RH, Wang Y, Nguyen X, Welsh JB. Acceptability and utility of the mySentry remote glucose monitoring system. J Diabetes Sci Technol 2013;7:356-61.
19. Christiansen M, Bailey T, Watkins E, Liljenquist D, Price D, Nakamura K, Boock R, Peyser T. A new-generation continuous glucose monitoring system: Improved accuracy and reliability compared with a previous-generation system. Diabetes Technol Ther 2013; Jun. 18. [Epub ahead of print]; DOI: 10.1089/dia.2013.0077.
20. Markowitz JT, Pratt K, Aggarwal J, Volkening LK, Laffel LM. Psychosocial correlates of continuous glucose monitoring use in youth and adults with type 1diabetes and parents of youth. Diabetes Technol Ther 2012;14:523-26.